Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia - PubMed (original) (raw)
Case Reports
Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia
M Briz et al. Br J Haematol. 1997 Aug.
Free article
Abstract
Epstein-Barr virus associated lymphoproliferative disease after autologous bone marrow transplantation (ABMT) has rarely been reported. We report a case of B-cell lymphoma following ABMT for T-acute lymphoblastic leukaemia; bone marrow was purged in vitro with monoclonal antibodies to remove T cells. Immunoglobulin and T-cell receptor gene rearrangement studies were used to demonstrate clonality and to show that this patient developed a second neoplasm after ABMT. EBV proteins and genome (type A) were present in post-transplantation lymphoma, suggesting a causative role in its development.
Similar articles
- Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, et al. Papadopoulos EB, et al. N Engl J Med. 1994 Apr 28;330(17):1185-91. doi: 10.1056/NEJM199404283301703. N Engl J Med. 1994. PMID: 8093146 - Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
Lacoste V, Judde JG, Bestett G, Cadranel J, Antoine M, Valensi F, Delabesse E, Macintyre E, Gessain A. Lacoste V, et al. Leuk Lymphoma. 2000 Jul;38(3-4):401-9. doi: 10.3109/10428190009087032. Leuk Lymphoma. 2000. PMID: 10830748 - T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma.
Vrsalovic MM, Korac P, Dominis M, Ostojic S, Mannhalter C, Kusec R. Vrsalovic MM, et al. Hematol Oncol. 2004 Dec;22(4):169-77. doi: 10.1002/hon.740. Hematol Oncol. 2004. PMID: 16134192 - Clinicopathologic implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients.
Thomas JA, Crawford DH, Burke M. Thomas JA, et al. J Clin Pathol. 1995 Apr;48(4):287-90. doi: 10.1136/jcp.48.4.287. J Clin Pathol. 1995. PMID: 7615843 Free PMC article. Review. No abstract available. - Epstein-Barr virus and its possible role in the pathogenesis of B-cell lymphomas.
Oudejans JJ, Jiwa NM, van den Brule AJ, Meijer CJ. Oudejans JJ, et al. Crit Rev Oncol Hematol. 1997 Feb;25(2):127-38. doi: 10.1016/s1040-8428(97)00233-3. Crit Rev Oncol Hematol. 1997. PMID: 9134314 Review. No abstract available.
Cited by
- Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy.
Viola GM, Zu Y, Baker KR, Aslam S. Viola GM, et al. Med Oncol. 2011 Dec;28(4):1604-8. doi: 10.1007/s12032-010-9635-8. Epub 2010 Aug 3. Med Oncol. 2011. PMID: 20680523 - Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Nash RA, Dansey R, Storek J, Georges GE, Bowen JD, Holmberg LA, Kraft GH, Mayes MD, McDonagh KT, Chen CS, Dipersio J, Lemaistre CF, Pavletic S, Sullivan KM, Sunderhaus J, Furst DE, McSweeney PA. Nash RA, et al. Biol Blood Marrow Transplant. 2003 Sep;9(9):583-91. doi: 10.1016/s1083-8791(03)00228-3. Biol Blood Marrow Transplant. 2003. PMID: 14506660 Free PMC article. Clinical Trial. - A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV. Perrine SP, et al. Blood. 2007 Mar 15;109(6):2571-8. doi: 10.1182/blood-2006-01-024703. Epub 2006 Nov 21. Blood. 2007. PMID: 17119113 Free PMC article. Clinical Trial. - A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma.
Zeng Q, Zhang H, Kuang P, Li J, Chen X, Dong T, Wu Q, Zhang C, Chen C, Niu T, Liu T, Liu Z, Ji J. Zeng Q, et al. Front Oncol. 2023 Mar 9;13:1143556. doi: 10.3389/fonc.2023.1143556. eCollection 2023. Front Oncol. 2023. PMID: 36969020 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical